Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > What next?
View:
Post by biorun on Apr 01, 2021 9:22am

What next?

Buyout in the air? Will they even get to the list before its all over?

Interesting they are tweeting about this:

"We have developed a compound library based on the antifreeze glycoproteins found in Antarctic fish. Synthesized glycoproteins and glycopeptides protect also against UV light, oxidation and nutrient deprivation. Learn more: sironabiochem.com/programs/anti-… 
#antiaging #cosmetics #biotech"
Comment by str8goods4achg on Apr 01, 2021 10:42am
If they can continue to validate molecules in their compound library then that would easily support Howard's forward thinking statement of becoming "a profitable broadly diversified large company" published in the R + F Dark Sport Corrector news release.. Generating some nice news momentum here. GLTA
Comment by lscfa on Apr 01, 2021 1:08pm
The co. should make each NR a stand alone document and not rely on readers remembering past NRs. Idiots did not even mention in latest NR a pharma partner.  Oct. 13, 2020 - Sirona is pleased to announce that it has signed an agreement with a top 10 global pharmaceutical company to jointly test Sirona's novel skin care, dark spot remover, TFC-1067, in a new clinical study ...more  
Comment by sam2100 on Apr 01, 2021 4:32pm
I agree with you there !
Comment by MirrorWorldMan on Apr 01, 2021 6:30pm
Well said iscfa, anothet overlooked point is the BP Co. partner created the protocol and endpoints themselves in conjunction with Sirona. It was reported that all of the reported endpoints were achieved with the undeniable 100% of participants. Hence, the partner's paid study achieved the partners desired predetermined results.  The 1067 proved itself again using their own evaluation ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities